, is paying a price that is 340% higher than where Medicines was trading at the beginning of the year, Cramer noted. Yet the Swiss pharmaceutical giant still saw its stock rise more than 1% Monday.
But beyond the recently announced deals, Cramer said, the market reaction makes him believe that further acquisitions could be on the horizon. Among the areas he suggested could be ripe for consolidation: some underperforming retail operations, software companies that specifically deal with cybersecurity, and banks, particularly when it comes to smaller, regional players."We have too many payments companies," Cramer said.
A lot of stocks are currently undervalued
Isn’t it all just about the incestuous “executive management” club?
NorthmanTrader
Jim Cramer likes the pajama boys now.
Or that billionaires have a lot of money to burn!
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »